Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Savers
SVV
$1.65B
| $2.57M | ﹤0.01% |
255,091
+90,973
| +55% | +$789K |
|
1627
PUT
PepsiCo
PEP
$196B
| $2.57M | ﹤0.01% |
19,000
-2,100
| -10% | -$314K |
|
1628
CALL
Royal Caribbean
RCL
$78.1B
| $2.57M | ﹤0.01% |
8,100
-16,600
| -67% | -$4.64M |
|
|
HAWK
1629
HawkEye 360 Inc
HAWK
$2.1B
| $2.57M | ﹤0.01% |
+126,925
| New | +$3.51M |
|
1630
US Physical Therapy
USPH
$1.17B
| $2.57M | ﹤0.01% |
37,362
+17,986
| +93% | +$1.22M |
|
1631
SolarEdge
SEDG
$1.9B
| $2.57M | ﹤0.01% |
+43,898
| New | +$2.3M |
|
1632
Equitable Holdings
EQH
$13.3B
| $2.56M | ﹤0.01% |
+58,248
| New | +$2.44M |
|
1633
U-Haul Holding Co
UHAL
$13.9B
| $2.55M | ﹤0.01% |
+38,963
| New | +$2.14M |
|
1634
FuboTV Inc
FUBO
$309M
| $2.55M | ﹤0.01% |
277,115
+95,393
| +52% | +$1.02M |
|
1635
Wolfspeed
WOLF
$1.34B
| $2.54M | ﹤0.01% |
52,629
-74,877
| -59% | -$3.26M |
|
1636
CALL
FedEx
FDX
$76.9B
| $2.54M | ﹤0.01% |
8,100
-2,500
| -24% | -$908K |
|
1637
Fulcrum Therapeutics
FULC
$292M
| $2.53M | ﹤0.01% |
692,372
-1,087,574
| -61% | -$6.62M |
|
1638
Banner Corp
BANR
$2.42B
| $2.53M | ﹤0.01% |
38,068
+26,309
| +224% | +$1.71M |
|
1639
Ethan Allen Interiors
ETD
$595M
| $2.53M | ﹤0.01% |
113,178
-83,427
| -42% | -$1.77M |
|
1640
Talos Energy
TALO
$2.92B
| $2.51M | ﹤0.01% |
194,738
+148,414
| +320% | +$2.21M |
|
1641
Tenaris
TS
$26.6B
| $2.51M | ﹤0.01% |
+45,238
| New | +$2.75M |
|
1642
Heritage Insurance Holdings
HRTG
$1.01B
| $2.5M | ﹤0.01% |
+95,993
| New | +$2.39M |
|
1643
CALL
UBS Group
UBS
$163B
| $2.5M | ﹤0.01% |
50,500
-231,700
| -82% | -$10.6M |
|
1644
Lantronix
LTRX
$267M
| $2.5M | ﹤0.01% |
+425,000
| New | +$2.72M |
|
1645
PUT
Core Scientific
CORZ
$5.72B
| $2.5M | ﹤0.01% |
+97,600
| New | +$2.3M |
|
1646
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$4.63B
| $2.49M | ﹤0.01% |
+23,300
| New | +$2.74M |
|
|
MPT
1647
Medical Properties Trust
MPT
$2.46B
| $2.49M | ﹤0.01% |
538,833
-17,541
| -3% | -$86.9K |
|
1648
Accenture
ACN
$113B
| $2.49M | ﹤0.01% |
19,981
+10,797
| +118% | +$1.87M |
|
1649
PUT
Chipotle Mexican Grill
CMG
$46.7B
| $2.49M | ﹤0.01% |
73,100
+14,300
| +24% | +$467K |
|
|
ETOR
1650
eToro Group
ETOR
$2.41B
| $2.49M | ﹤0.01% |
62,963
-70,896
| -53% | -$2.67M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.